<p>随着全球市场持续波动，亚洲指数在地缘政治紧张局势和经济变动中表现出韧性，投资者越来越关注具有强劲增长潜力和显著内部持股的公司。在这种背景下，像衢州新安发展这样的股票脱颖而出，因为它们结合了良好的增长前景和高水平的内部投资，这通常可以表明对公司未来表现的信心。</p>
<h3>亚洲内部持股高的十大成长公司</h3>
<table>
<thead>
<tr>
<th></th>
<th></th>
<th></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>名称</strong></td>
<td><strong>内部持股</strong></td>
<td><strong>收益增长</strong></td>
</tr>
<tr>
<td>UTI (KOSDAQ:A179900)</td>
<td>25%</td>
<td>120.7%</td>
</tr>
<tr>
<td>Streamax Technology (SZSE:002970)</td>
<td>32.5%</td>
<td>33.1%</td>
</tr>
<tr>
<td>Seers Technology (KOSDAQ:A458870)</td>
<td>33.9%</td>
<td>78.8%</td>
</tr>
<tr>
<td>Phison Electronics (TPEX:8299)</td>
<td>10.8%</td>
<td>29.8%</td>
</tr>
<tr>
<td>Novoray (SHSE:688300)</td>
<td>23.6%</td>
<td>31.4%</td>
</tr>
<tr>
<td>Modetour Network (KOSDAQ:A080160)</td>
<td>12.7%</td>
<td>41.8%</td>
</tr>
<tr>
<td>Loadstar Capital K.K (TSE:3482)</td>
<td>31%</td>
<td>23.6%</td>
</tr>
<tr>
<td>Gold Circuit Electronics (TWSE:2368)</td>
<td>31.4%</td>
<td>37.5%</td>
</tr>
<tr>
<td>FUNDINNOInc (TSE:462A)</td>
<td>34.4%</td>
<td>53.7%</td>
</tr>
<tr>
<td>Fulin Precision (SZSE:300432)</td>
<td>10.6%</td>
<td>55.2%</td>
</tr>
</tbody>
</table>
<p>点击这里查看我们快速成长的亚洲内部持股高的 620 只股票的完整列表。</p>
<p>下面我们重点介绍几只我们独特筛选器中的最爱。</p>
<h2>衢州新安发展 (SHSE:600208)</h2>
<p><strong>Simply Wall St 成长评级：</strong> ★★★★★☆</p>
<p><strong>概述：</strong> 衢州新安发展有限公司在中国从事房地产开发和金融服务，市值为 347.1 亿人民币。</p>
<p><strong>运营：</strong> 公司的收入来源包括中国的房地产开发和金融服务。</p>
<p><strong>内部持股：</strong> 17.2%</p>
<p>衢州新安发展有望实现显著增长，预计年收入增长 47.6%，超过中国市场的平均水平。尽管最近销售和净收入有所下降，但预计公司将在三年内实现盈利，超越平均市场增长率。然而，由于经营现金流对债务的覆盖不足以及预计的股本回报率仅为 4.7%，其财务健康状况仍然令人担忧。</p>
<ul>
<li>解锁我们对衢州新安发展股票分析的全面见解，详见本成长报告。</li>
<li>我们最近的估值报告指出，衢州新安发展股票在市场上可能被高估。</li>
</ul>
<p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/eca9c479-dccf-4060-9041-07515f959162/chart/earnings-and-revenue-growth?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/eca9c479-dccf-4060-9041-07515f959162/chart/earnings-and-revenue-growth"/></p>
<p>SHSE:600208 截至 2026 年 1 月的收益和收入增长</p>
<h2>宁波三兴医疗电气有限公司 (SHSE:601567)</h2>
<p><strong>Simply Wall St 成长评级：</strong> ★★★★★☆</p>
<p><strong>概述：</strong> 宁波三兴医疗电气有限公司在中国及国际上制造和销售电力分配产品，市值为 343.6 亿人民币。</p>
<p><strong>运营：</strong> 宁波三兴医疗电气有限公司通过制造和销售电力分配产品在国内外产生收入。</p>
<p><strong>内部持股：</strong> 23.7%</p>
<p>宁波三兴医疗电气有限公司的交易价格低于其估计的公允价值，相较于同行提供了良好的相对价值。尽管股价波动较大，但预计收益将显著增长，年增长率为 28.1%，超过更广泛的中国市场增长率 27.9%。然而，最近的收益报告显示净收入同比下降至 15.2783 亿人民币，去年为 18.157 亿人民币。分析师预计股价将上涨 24%，尽管由于收益或自由现金流的覆盖不足，股息的可持续性仍然存疑。</p>
<ul>
<li>点击探索我们在宁波三兴医疗电气有限公司收益增长报告中的详细发现。</li>
<li>根据我们最近的估值报告，宁波三兴医疗电气有限公司的交易价格似乎低于其估计价值。</li>
</ul>
<p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/2ee373e6-53d5-4c83-90e5-36fd85262791/chart/earnings-and-revenue-growth?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/2ee373e6-53d5-4c83-90e5-36fd85262791/chart/earnings-and-revenue-growth"/></p>
<p>SHSE:601567 截至 2026 年 1 月的收益和收入增长</p>
<h2>概伦科技 (SHSE:688206)</h2>
<p><strong>Simply Wall St 成长评级：</strong> ★★★★☆☆</p>
<p><strong>概述：</strong> 概伦科技有限公司从事电子设计自动化（EDA）工具的研究、设计和开发，市值为 172.5 亿人民币。</p>
<p><strong>运营：</strong> 公司的收入主要来自 EDA 解决方案，金额为 4.5455 亿人民币。</p>
<p><strong>内部持股：</strong> 16.1%</p>
<p>概伦科技的内部持股显著，最近的交易表明上海新合创收购了 5% 的股份。公司财务恢复显著，报告净收入为 4199 万人民币，而之前为亏损。预计收入年增长率为 19.7%，超过更广泛的中国市场增长率 14.6%。尽管有这种增长潜力，但公司的股本回报率仍然较低，股价波动性高。</p>
<ul>
<li>深入了解概伦科技的完整分析未来增长报告。</li>
<li>根据我们最近的估值报告，概伦科技的交易价格似乎超出了其估计价值。</li>
</ul>
<p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/290ef310-da69-44c1-97a4-a1119e0111aa/chart/earnings-and-revenue-growth?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/290ef310-da69-44c1-97a4-a1119e0111aa/chart/earnings-and-revenue-growth"/></p>
<p>SHSE:688206 截至 2026 年 1 月的收益和收入增长</p>
<h2>关键要点</h2>
<ul>
<li>通过使用我们的筛选器，深入了解 620 家快速成长的亚洲内部持股高的公司。</li>
<li>寻找替代机会？人工智能即将改变医疗保健。这 30 只股票正在从早期诊断到药物发现的各个方面进行工作。最重要的是——它们的市值都在 100 亿美元以下——仍然有机会提前布局。</li>
</ul>
<p><em>这篇来自 Simply Wall St 的文章具有一般性。<strong>我们提供的评论基于历史数据和分析师预测，仅使用无偏见的方法，我们的文章并不旨在提供财务建议。</strong> 这并不构成买入或卖出任何股票的推荐，也未考虑您的目标或财务状况。我们的目标是为您提供以基本数据驱动的长期分析。请注意，我们的分析可能未考虑最新的价格敏感公司公告或定性材料。Simply Wall St 在提到的任何股票中均没有持仓。该分析仅考虑内部人士直接持有的股票，不包括通过其他工具（如公司和/或信托实体）间接持有的股票。所有预测的收入和收益增长率均以年化（每年）增长率的形式表示，时间范围为 1-3 年。</em></p>

三星医疗

概伦电子

<p>随着全球市场波动，投资者正关注具有强劲增长潜力和高内部持股比例的亚洲公司。尽管财务健康状况存在担忧，衢州新安发展以 17.2% 的内部持股比例和预计 47.6% 的收入增长脱颖而出。其他值得注意的公司包括宁波三星医疗电气，预计盈利增长 28.1%，以及概伦电子，内部持股比例为 16.1%，收入增长预测为 19.7%。这些公司反映出在市场波动中，投资者倾向于投资于内部信心显著的企业</p>

<p>As global markets continue to experience fluctuations, with Asian indices showing resilience amid geopolitical tensions and economic shifts, investors are increasingly focusing on companies with strong growth potential and significant insider ownership. In this context, stocks like Quzhou Xin'an Development stand out as they combine promising growth prospects with high levels of insider investment, which can often signal confidence in a company's future performance.</p>
<div class="lb-trans"><p>随着全球市场持续波动，亚洲指数在地缘政治紧张局势和经济变动中表现出韧性，投资者越来越关注具有强劲增长潜力和显著内部持股的公司。在这种背景下，像衢州新安发展这样的股票脱颖而出，因为它们结合了良好的增长前景和高水平的内部投资，这通常可以表明对公司未来表现的信心。</p>
</div><h3>Top 10 Growth Companies With High Insider Ownership In Asia</h3>
<div class="lb-trans"><h3>亚洲内部持股高的十大成长公司</h3>
</div><table>
<thead>
<tr>
<th></th>
<th></th>
<th></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>Name</strong></td>
<td><strong>Insider Ownership</strong></td>
<td><strong>Earnings Growth</strong></td>
</tr>
<tr>
<td>UTI (KOSDAQ:A179900)</td>
<td>25%</td>
<td>120.7%</td>
</tr>
<tr>
<td>Streamax Technology (SZSE:002970)</td>
<td>32.5%</td>
<td>33.1%</td>
</tr>
<tr>
<td>Seers Technology (KOSDAQ:A458870)</td>
<td>33.9%</td>
<td>78.8%</td>
</tr>
<tr>
<td>Phison Electronics (TPEX:8299)</td>
<td>10.8%</td>
<td>29.8%</td>
</tr>
<tr>
<td>Novoray (SHSE:688300)</td>
<td>23.6%</td>
<td>31.4%</td>
</tr>
<tr>
<td>Modetour Network (KOSDAQ:A080160)</td>
<td>12.7%</td>
<td>41.8%</td>
</tr>
<tr>
<td>Loadstar Capital K.K (TSE:3482)</td>
<td>31%</td>
<td>23.6%</td>
</tr>
<tr>
<td>Gold Circuit Electronics (TWSE:2368)</td>
<td>31.4%</td>
<td>37.5%</td>
</tr>
<tr>
<td>FUNDINNOInc (TSE:462A)</td>
<td>34.4%</td>
<td>53.7%</td>
</tr>
<tr>
<td>Fulin Precision (SZSE:300432)</td>
<td>10.6%</td>
<td>55.2%</td>
</tr>
</tbody>
</table>
<div class="lb-trans"><table>
<thead>
<tr>
<th></th>
<th></th>
<th></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>名称</strong></td>
<td><strong>内部持股</strong></td>
<td><strong>收益增长</strong></td>
</tr>
<tr>
<td>UTI (KOSDAQ:A179900)</td>
<td>25%</td>
<td>120.7%</td>
</tr>
<tr>
<td>Streamax Technology (SZSE:002970)</td>
<td>32.5%</td>
<td>33.1%</td>
</tr>
<tr>
<td>Seers Technology (KOSDAQ:A458870)</td>
<td>33.9%</td>
<td>78.8%</td>
</tr>
<tr>
<td>Phison Electronics (TPEX:8299)</td>
<td>10.8%</td>
<td>29.8%</td>
</tr>
<tr>
<td>Novoray (SHSE:688300)</td>
<td>23.6%</td>
<td>31.4%</td>
</tr>
<tr>
<td>Modetour Network (KOSDAQ:A080160)</td>
<td>12.7%</td>
<td>41.8%</td>
</tr>
<tr>
<td>Loadstar Capital K.K (TSE:3482)</td>
<td>31%</td>
<td>23.6%</td>
</tr>
<tr>
<td>Gold Circuit Electronics (TWSE:2368)</td>
<td>31.4%</td>
<td>37.5%</td>
</tr>
<tr>
<td>FUNDINNOInc (TSE:462A)</td>
<td>34.4%</td>
<td>53.7%</td>
</tr>
<tr>
<td>Fulin Precision (SZSE:300432)</td>
<td>10.6%</td>
<td>55.2%</td>
</tr>
</tbody>
</table>
</div><p>Click here to see the full list of 620 stocks from our Fast Growing Asian Companies With High Insider Ownership screener.</p>
<div class="lb-trans"><p>点击这里查看我们快速成长的亚洲内部持股高的 620 只股票的完整列表。</p>
</div><p>Below we spotlight a couple of our favorites from our exclusive screener.</p>
<div class="lb-trans"><p>下面我们重点介绍几只我们独特筛选器中的最爱。</p>
</div><h2>Quzhou Xin'an Development (SHSE:600208)</h2>
<div class="lb-trans"><h2>衢州新安发展 (SHSE:600208)</h2>
</div><p><strong>Simply Wall St Growth Rating:</strong> ★★★★★☆</p>
<div class="lb-trans"><p><strong>Simply Wall St 成长评级：</strong> ★★★★★☆</p>
</div><p><strong>Overview:</strong> Quzhou Xin'an Development Co., Ltd. operates in real estate development and financial services in China, with a market cap of CN¥34.71 billion.</p>
<div class="lb-trans"><p><strong>概述：</strong> 衢州新安发展有限公司在中国从事房地产开发和金融服务，市值为 347.1 亿人民币。</p>
</div><p><strong>Operations:</strong> The company's revenue segments include real estate development and financial services in China.</p>
<div class="lb-trans"><p><strong>运营：</strong> 公司的收入来源包括中国的房地产开发和金融服务。</p>
</div><p><strong>Insider Ownership:</strong> 17.2%</p>
<div class="lb-trans"><p><strong>内部持股：</strong> 17.2%</p>
</div><p>Quzhou Xin'an Development is poised for substantial growth, with revenue projected to increase by 47.6% annually, outpacing the Chinese market's average. Despite a recent decline in sales and net income, the company is expected to become profitable within three years, surpassing average market growth rates. However, its financial health remains a concern due to inadequate debt coverage by operating cash flow and a forecasted low return on equity of 4.7%.</p>
<div class="lb-trans"><p>衢州新安发展有望实现显著增长，预计年收入增长 47.6%，超过中国市场的平均水平。尽管最近销售和净收入有所下降，但预计公司将在三年内实现盈利，超越平均市场增长率。然而，由于经营现金流对债务的覆盖不足以及预计的股本回报率仅为 4.7%，其财务健康状况仍然令人担忧。</p>
</div><ul>
<li>Unlock comprehensive insights into our analysis of Quzhou Xin'an Development stock in this growth report.</li>
<li>Insights from our recent valuation report point to the potential overvaluation of Quzhou Xin'an Development shares in the market.</li>
</ul>
<div class="lb-trans"><ul>
<li>解锁我们对衢州新安发展股票分析的全面见解，详见本成长报告。</li>
<li>我们最近的估值报告指出，衢州新安发展股票在市场上可能被高估。</li>
</ul>
</div><p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/eca9c479-dccf-4060-9041-07515f959162/chart/earnings-and-revenue-growth" alt="" original-src="https://images.simplywall.st/company/eca9c479-dccf-4060-9041-07515f959162/chart/earnings-and-revenue-growth"/></p>
<p>SHSE:600208 Earnings and Revenue Growth as at Jan 2026</p>
<div class="lb-trans"><p>SHSE:600208 截至 2026 年 1 月的收益和收入增长</p>
</div><h2>Ningbo Sanxing Medical ElectricLtd (SHSE:601567)</h2>
<div class="lb-trans"><h2>宁波三兴医疗电气有限公司 (SHSE:601567)</h2>
</div><p><strong>Simply Wall St Growth Rating:</strong> ★★★★★☆</p>
<div class="lb-trans"><p><strong>Simply Wall St 成长评级：</strong> ★★★★★☆</p>
</div><p><strong>Overview:</strong> Ningbo Sanxing Medical Electric Co., Ltd. manufactures and sells power distribution products in China and internationally, with a market cap of CN¥34.36 billion.</p>
<div class="lb-trans"><p><strong>概述：</strong> 宁波三兴医疗电气有限公司在中国及国际上制造和销售电力分配产品，市值为 343.6 亿人民币。</p>
</div><p><strong>Operations:</strong> Ningbo Sanxing Medical Electric Co., Ltd. generates its revenue through the manufacturing and sale of power distribution products both domestically and globally.</p>
<div class="lb-trans"><p><strong>运营：</strong> 宁波三兴医疗电气有限公司通过制造和销售电力分配产品在国内外产生收入。</p>
</div><p><strong>Insider Ownership:</strong> 23.7%</p>
<div class="lb-trans"><p><strong>内部持股：</strong> 23.7%</p>
</div><p>Ningbo Sanxing Medical Electric Ltd. is trading below its estimated fair value and offers good relative value compared to peers. Despite a volatile share price, earnings are forecasted to grow significantly at 28.1% annually, surpassing the broader Chinese market growth rate of 27.9%. However, recent earnings reports show a decline in net income to CNY 1,527.83 million from CNY 1,815.7 million year-on-year. Analysts expect a stock price rise by 24%, although dividend sustainability remains questionable due to inadequate coverage by earnings or free cash flows.</p>
<div class="lb-trans"><p>宁波三兴医疗电气有限公司的交易价格低于其估计的公允价值，相较于同行提供了良好的相对价值。尽管股价波动较大，但预计收益将显著增长，年增长率为 28.1%，超过更广泛的中国市场增长率 27.9%。然而，最近的收益报告显示净收入同比下降至 15.2783 亿人民币，去年为 18.157 亿人民币。分析师预计股价将上涨 24%，尽管由于收益或自由现金流的覆盖不足，股息的可持续性仍然存疑。</p>
</div><ul>
<li>Click to explore a detailed breakdown of our findings in Ningbo Sanxing Medical ElectricLtd's earnings growth report.</li>
<li>In light of our recent valuation report, it seems possible that Ningbo Sanxing Medical ElectricLtd is trading behind its estimated value.</li>
</ul>
<div class="lb-trans"><ul>
<li>点击探索我们在宁波三兴医疗电气有限公司收益增长报告中的详细发现。</li>
<li>根据我们最近的估值报告，宁波三兴医疗电气有限公司的交易价格似乎低于其估计价值。</li>
</ul>
</div><p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/2ee373e6-53d5-4c83-90e5-36fd85262791/chart/earnings-and-revenue-growth" alt="" original-src="https://images.simplywall.st/company/2ee373e6-53d5-4c83-90e5-36fd85262791/chart/earnings-and-revenue-growth"/></p>
<p>SHSE:601567 Earnings and Revenue Growth as at Jan 2026</p>
<div class="lb-trans"><p>SHSE:601567 截至 2026 年 1 月的收益和收入增长</p>
</div><h2>Primarius Technologies (SHSE:688206)</h2>
<div class="lb-trans"><h2>概伦科技 (SHSE:688206)</h2>
</div><p><strong>Simply Wall St Growth Rating:</strong> ★★★★☆☆</p>
<div class="lb-trans"><p><strong>Simply Wall St 成长评级：</strong> ★★★★☆☆</p>
</div><p><strong>Overview:</strong> Primarius Technologies Co., Ltd. is engaged in the research, design, and development of electronic design automation (EDA) tools both in China and internationally, with a market cap of CN¥17.25 billion.</p>
<div class="lb-trans"><p><strong>概述：</strong> 概伦科技有限公司从事电子设计自动化（EDA）工具的研究、设计和开发，市值为 172.5 亿人民币。</p>
</div><p><strong>Operations:</strong> The company's revenue is primarily generated from EDA Solutions, amounting to CN¥454.55 million.</p>
<div class="lb-trans"><p><strong>运营：</strong> 公司的收入主要来自 EDA 解决方案，金额为 4.5455 亿人民币。</p>
</div><p><strong>Insider Ownership:</strong> 16.1%</p>
<div class="lb-trans"><p><strong>内部持股：</strong> 16.1%</p>
</div><p>Primarius Technologies exhibits substantial insider ownership, with recent transactions indicating a 5% stake acquisition by Shanghai Xinhechuang. The company has shown impressive financial recovery, reporting a net income of CNY 41.99 million compared to a loss previously. Revenue is expected to grow at 19.7% annually, outpacing the broader Chinese market's growth rate of 14.6%. Despite this growth potential, the company's return on equity remains low and share price volatility is high.</p>
<div class="lb-trans"><p>概伦科技的内部持股显著，最近的交易表明上海新合创收购了 5% 的股份。公司财务恢复显著，报告净收入为 4199 万人民币，而之前为亏损。预计收入年增长率为 19.7%，超过更广泛的中国市场增长率 14.6%。尽管有这种增长潜力，但公司的股本回报率仍然较低，股价波动性高。</p>
</div><ul>
<li>Delve into the full analysis future growth report here for a deeper understanding of Primarius Technologies.</li>
<li>In light of our recent valuation report, it seems possible that Primarius Technologies is trading beyond its estimated value.</li>
</ul>
<div class="lb-trans"><ul>
<li>深入了解概伦科技的完整分析未来增长报告。</li>
<li>根据我们最近的估值报告，概伦科技的交易价格似乎超出了其估计价值。</li>
</ul>
</div><p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/290ef310-da69-44c1-97a4-a1119e0111aa/chart/earnings-and-revenue-growth" alt="" original-src="https://images.simplywall.st/company/290ef310-da69-44c1-97a4-a1119e0111aa/chart/earnings-and-revenue-growth"/></p>
<p>SHSE:688206 Earnings and Revenue Growth as at Jan 2026</p>
<div class="lb-trans"><p>SHSE:688206 截至 2026 年 1 月的收益和收入增长</p>
</div><h2>Key Takeaways</h2>
<div class="lb-trans"><h2>关键要点</h2>
</div><ul>
<li>Get an in-depth perspective on all 620 Fast Growing Asian Companies With High Insider Ownership by using our screener here.</li>
<li>Looking For Alternative Opportunities? AI is about to change healthcare. These 30 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10b in market cap - there's still time to get in early.</li>
</ul>
<div class="lb-trans"><ul>
<li>通过使用我们的筛选器，深入了解 620 家快速成长的亚洲内部持股高的公司。</li>
<li>寻找替代机会？人工智能即将改变医疗保健。这 30 只股票正在从早期诊断到药物发现的各个方面进行工作。最重要的是——它们的市值都在 100 亿美元以下——仍然有机会提前布局。</li>
</ul>
</div><p><em>This article by Simply Wall St is general in nature. <strong>We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice.</strong> It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.The analysis only considers stock directly held by insiders. It does not include indirectly owned stock through other vehicles such as corporate and/or trust entities. All forecast revenue and earnings growth rates quoted are in terms of annualised (per annum) growth rates over 1-3 years.</em></p>
<div class="lb-trans"><p><em>这篇来自 Simply Wall St 的文章具有一般性。<strong>我们提供的评论基于历史数据和分析师预测，仅使用无偏见的方法，我们的文章并不旨在提供财务建议。</strong> 这并不构成买入或卖出任何股票的推荐，也未考虑您的目标或财务状况。我们的目标是为您提供以基本数据驱动的长期分析。请注意，我们的分析可能未考虑最新的价格敏感公司公告或定性材料。Simply Wall St 在提到的任何股票中均没有持仓。该分析仅考虑内部人士直接持有的股票，不包括通过其他工具（如公司和/或信托实体）间接持有的股票。所有预测的收入和收益增长率均以年化（每年）增长率的形式表示，时间范围为 1-3 年。</em></p>
</div>

由衢州新安发展公司领导的亚洲增长型公司具有高内部持股比例